The Potential Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in Elderly People and Clinical Risk Groups in the UK: A Lifetime Multi-Cohort Model

Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation

(2014) P Tappenden et al.   HEALTH TECHNOLOGY ASSESSMENT

Vaccine for Prevention of Mild and Moderate-to-Severe Influenza in Children

(2013) Varsha K. Jain et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hospitalizations Associated With Influenza and Respiratory Syncytial Virus in the United States, 1993–2008

(2012) Hong Zhou et al.   CLINICAL INFECTIOUS DISEASES

Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: A systematic review with meta-analyses of controlled trials

(2012) Carlos A. DiazGranados et al.   VACCINE

Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine

(2012) Carrie Reed et al.   VACCINE

Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004-2005 through 2007-2008

(2011) Stephanie A. Irving et al.   Influenza and Other Respiratory Viruses

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

(2011) Michael T Osterholm et al.   LANCET INFECTIOUS DISEASES

The need for quadrivalent vaccine against seasonal influenza

(2010) Robert B. Belshe   VACCINE

Pharmacoeconomics: NICE's approach to decision-making

(2009) Michael Rawlins et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Estimates of US influenza-associated deaths made using four different methods

(2009) William W. Thompson et al.   Influenza and Other Respiratory Viruses